Yu Yongguo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SHANGHAI, Nov. 16, 2023 /PRNewswire/  VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to

United statesHong kongT ai peiAscendis pharmaYu yongguoNational health commissionEuropean commissionDrug administrationTranscon technologyNational health commission onClinical genetics centerShanghai jiao tong university school of medicineNational healthExecutive directorXinhua hospitalShanghai jiao tong university school